Quantcast

Latest Ketones Stories

2014-06-12 16:26:24

SAN FRANCISCO, June 12, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported today that partner AstraZeneca announced that the majority of US Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) members voted that the FDA should not require cardiovascular outcomes trials for the peripherally-acting mu-opioid receptor antagonist (PAMORA) class of drugs, which includes MOVANTIK(TM )(naloxegol oxalate), an investigational...

2014-06-12 12:28:55

LONDON, June 12, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Moderate Pain - Pipeline Review, H1 2014 http://www.reportbuyer.com/pharma_healthcare/treatments/moderate_pain_pipeline_review_h1_2013.html Moderate Pain - Pipeline Review, H1 2014 Summary Global Markets Direct's, 'Moderate Pain - Pipeline Review, H1 2014', provides an overview of the Moderate Pain's therapeutic pipeline. This report provides comprehensive information on the therapeutic...

2014-06-11 23:00:39

Sunshine Summit Lodge, a Narconon drug rehabilitation program in California, has witnessed the trend of initial drug use change from illicit drugs over to prescription painkillers over the last decade. Because of recent news about the prescription epidemic, the facility is offering solutions through a new series of articles through it’s website, as well as effective treatment. (PRWEB) June 11, 2014 According to the CDC (The Center for Disease Control and Prevention), deaths from...

2014-06-11 12:26:03

President and CEO Mark A. Sirgo Describes BUNAVAIL(TM) Delivery, Competitive Advantages, Market Size and Patient Need RALEIGH, N.C., June 11, 2014 /PRNewswire/ -- Dr. Mark A. Sirgo, President and Chief Executive Officer of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) was interviewed on Bloomberg TV, TheStreet.com and Business News Network on June 11 regarding BUNAVAIL, BDSI's product for the maintenance treatment of opioid dependence that recently received approval from...

2014-06-11 08:28:27

DATA FROM KINECT 1 AND KINECT 2 TARDIVE DYSKINESIA STUDIES SAN DIEGO, June 11, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that on June 11, 2014, two scientific posters associated with its study of NBI-98854 in Phase IIb clinical trials of tardive dyskinesia patients, will be presented at the 2014 Annual Congress of Parkinson's Disease and Movement Disorders in Stockholm Sweden. This annual meeting brings together over 5,000 clinicians and...

2014-06-06 23:01:39

TreatmentHelp helps debunk the claim that medication prescribed by a physician is always safer than illicit drugs. Delray Beach, FL (PRWEB) June 06, 2014 Prescription drugs have started to gain the notoriety of illicit drugs, especially among teenagers and individuals to whom the drugs were not prescribed. Taking prescription drugs without the supervision of a physician can be extremely dangerous and life-threatening to overall health and well-being. Some of the most commonly abused...

2014-06-06 23:01:17

A nasal-spray version of Naloxone, a heroin/opiate overdose-reversal drug, is in the works in Kentucky. (PRWEB) June 06, 2014 As reported by USA Today in the article Nasal Spray For Heroin Antidote Under Development(5/31), a Kentucky doctor has been successful in advocating a nasal spray medicine to reverse a heroin or opiate overdose. Dr. Daniel Wermeling has made a deal with a pharmaceutical company to create a nasal spray version of naloxone, a common medicine used on persons who are...

2014-06-06 16:24:14

First and Only FDA-Approved Buccal Film Formulation of Buprenorphine and Naloxone to Compete in the $1.7 Billion and Growing U.S. Opioid Dependence Market RALEIGH, N.C., June 6, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) received approval of the New Drug Application (NDA) for BUNAVAIL(TM) (buprenorphine and naloxone) buccal film (CIII) from the U.S. Food and Drug Administration (FDA). BUNAVAIL is indicated for the maintenance treatment of...

2014-06-05 23:11:58

Natural supplement company, PuraVida Labs, releases breakthrough new Forskolin formulation that is backed by science and helps women lose weight. Victor, NY (PRWEB) June 05, 2014 Forskolin is a natural extract that has been credited as an effective fat loss aid that soared to popularity when it was endorsed by a well-known television doctor recently. This week, PuraVida Labs, a natural supplement company, has released its Forskolin Extreme Thermogenesis Formula on Amazon. Company...

2014-06-05 13:33:09

University of Michigan Health System With naloxegol, adults found relief from opioid-induced constipation Pain medicines often lead to constipation for patients seeking long-term pain relief, but an investigational once-daily drug may help, according to study led by the University of Michigan Health System. Globally, approximately 28 million to 35 million, or nearly half, of patients taking opioids for long-term pain develop constipation. Laxatives provide sub-optimal relief. The...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related